Value stocks have been on a tear, while growth stocks and tech leaders have taken a back seat since late January. This has pressured the overall market indexes, e.g. the S&P 500 and the Nasdaq.
March volatility arrived as promised and next week could exacerbate into more weakness as put-call ratios continue to rise and market breath weakens. Pharma could become a safe haven in such a scenario. Dow stocks perform well in Post-election year Aprils.
Our US Trade Talk telegram channel has actively highlighted stocks of interest that have made significant moves in a short time frame, even in this weak period for the overall indexes.